Satisfaction with methadone as a medication: Psychometric properties of the Spanish version of the treatment satisfaction questionnaire for medication

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 69-74

  Trujols, Joan ^a   Iraurgi, Ioseba ^b   Siñol, Núria ^a   Portella, Maria J ^a   Pérez, Víctor ^a   Pérez De Los Cobos, José ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITY OF DEUSTO   (Spain)

Author keywords

methadone maintenance treatment; opioid dependence; patient reported outcomes; psychometric analyses; satisfaction with medication; Treatment Satisfaction Questionnaire for Medication

Indexed keywords

METHADONE;

ADULT; ARTICLE; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; STATISTICAL ANALYSIS; TREATMENT SATISFACTION QUESTIONNAIRE FOR MEDICATION;

ADULT; CROSS-CULTURAL COMPARISON; FEMALE; HEROIN DEPENDENCE; HUMANS; INFORMED CONSENT; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PATIENT PARTICIPATION; PATIENT SATISFACTION; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPAIN; TREATMENT OUTCOME;

EID: 84855340903     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182401e09     Document Type: Article

References (36)

1. Trujols J, Sinol N, Pérez de los Cobos J. Methadone maintenance treatment: the need to distinguish between holding dose, dose adequacy, satisfaction with methadone as a medication, and satisfaction with treatment. J Clin Psychopharmacol. 2010;30:95-96.
2. Elkader AK, Brands B, Callaghan R, et al. Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment. Drug Alcohol Depend. 2009;105:209-214.
3. Tacke U, Wolff K, Finch E, et al. The effect of tobacco smoking on subjective symptoms of inadequacy ("not holding") of methadone dose among opiate addicts in methadone maintenance treatment. Addict Biol. 2001;6:137-145. (Pubitemid 32436728)
4. González-Saiz F. Opiate Dosage Adequacy Scale (ODAS): a clinical diagnostic tool as a guide to dosing decisions. Heroin Addict Relat Clin Probl. 2004;6(3):41-50.
5. González-Saiz F, Lozano Rojas O, Ballesta Gómez R, et al. Evidence of reliability and validity of the Opiate Dosage Adequacy Scale (ODAS) in a sample of methadone maintenance patients. Heroin Addict Relat Clin Probl. 2008;10(1):25-38. (Pubitemid 351481978)
6. Pérez de los Cobos J, Valero S, Haro G, et al. Development and psychometric properties of the Verona Service Satisfaction Scale for methadone-treated opioid-dependent patients (VSSS-MT). Drug Alcohol Depend. 2002;68:209-214. (Pubitemid 35247792)
7. Kelly SM, O'Grady KE, Brown BS, et al. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010;36:150-154.
8. Ward J Part C. The case of community methadone treatment programs. In: World Health Organization, ed. Evaluation of Psychoactive Substance Use Disorder Treatment: Workbook 6 Client Satisfaction Evaluations. Geneva, Switzerland: World Health Organization; 2000:32-38.
9. Pérez de los Cobos J, Trujols J, Valderrama JC, et al. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug Alcohol Depend. 2005;79:405-412. (Pubitemid 41127170)
10. Ruiz MA, Pardo A, Rejas J, et al. Development and validation of the "Treatment Satisfaction with Medicines Questionnaire" (SATMED-Q). Value Health. 2008;11:913-926.
11. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health. 2004;7:204-215. (Pubitemid 38420733)
12. Kayman DJ, Goldstein MF, Deren S, et al. Predicting treatment retention with a brief "Opinions About Methadone" scale. J Psychoactive Drugs. 2006;38:93-100.
13. Rieckmann T, Daley M, Fuller BE, et al. Client and counselor attitudes toward the use of medications for treatment of opioid dependence. J Subst Abuse Treat. 2007;32:207-215. (Pubitemid 46240725)
14. Schwartz RP, Kelly SM, O'Grady KE, et al. Attitudes toward buprenorphine and methadone among opioid-dependent individuals. Am J Addict. 2008;17:396-401.
15. Stancliff S, Myers JE, Steiner S, et al. Beliefs about methadone in an inner-city methadone clinic. J Urban Health. 2002;79:571-578. (Pubitemid 36076530)
16. Anderson RT, Skovlund SE, Marrero D, et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther. 2004;26:565-578. (Pubitemid 38586458)
17. Atkinson MJ, Sinha A, Hass SL, et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004;2:12.
18. Carr AJ, Thompson PW, Cooper C. Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int. 2006;17:1638-1644. (Pubitemid 44477624)
19. Gharabawi GM, Greenspan A, Rupnow MF, et al. Reduction in psychotic symptoms as a predictor of patient satisfaction with antipsychotic medication in schizophrenia: data from a randomized double-blind trial. BMC Psychiatry. 2006;6:45.
20. Donatti C, Wild D, Horblyuk R, et al. Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS). Diabetes Res Clin Pract. 2008;80:108-113.
21. Fujikawa M, Togo T, Yoshimi A, et al. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:755-760. (Pubitemid 351312376)
22. Vernon MK, Revicki DA, Awad AG, et al. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients. Schizophr Res. 2010;118:271-278.
23. Brener L, Resnick I, Ellard J, et al. Exploring the role of consumer participation in drug treatment. Drug Alcohol Depend. 2009;105:172-175.
24. Satorra A, Bentler PM. Corrections to test statistics and standard errors in covariance structure analysis. In: von Eye A, Clogg CC, eds. Latent Variables Analysis: Applications for Developmental Research. Thousand Oaks, CA: Sage; 1994:399-419.
25. Yuan K-H, Bentler PM. Three likelihood-based methods for mean and covariance structure analysis with nonnormal missing data. Sociol Methodol. 2000;30:165-200. (Pubitemid 33233082)
26. Akaike H. Factor analysis and AIC. Psychometrika. 1987;52:317-332.
27. Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behav Res. 1990;25:173-180.
28. Bentler PM, Bonett DG. Significance test and goodness of fit in the analysis of covariance structures. Psychol Bull. 1980;88:588-606.
29. Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238-246.
30. Bollen KA. A new incremental fit index for general structural equation models. Sociol Methods Res. 1989;17:303-316.
31. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6:1-55.
32. Mueller RO, Hancock GR. Best practices in structural equation modeling. In: Osborne JW, ed. Best Practices in Quantitative Methods. Thousand Oaks, CA: Sage Publications 2008: 488-508
33. Bentler PM. EQS Structural Equations Program Manual. Encino, CA: Multivariate Software; 2006.
34. Zumbo BD, Gadermann AM, Zeisser C. Ordinal versions of coefficients alpha and theta for Likert rating scales. J Mod Appl Stat Methods. 2007;6:21-29.
35. Comrey AL, Lee HB. A First Course in Factor Analysis. 2nd ed. Mahwah, NJ: Lawrence Erlbaum; 1992.
36. Nunnally JC, Bernstein IH. Psychometric Theory. 3rd ed. New York, NY: McGraw-Hill; 1994.